Clinical Trial Update: Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dendritic cells combined with autologous tumor RNA for uveal melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Dendritic Cells Plus Autologous Tumor RNA

Snippet

Sponsor: University Hospital Erlangen | Conditions: Uveal Melanoma | Phase 3 | Status: COMPLETED